Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
7.26
-0.09 (-1.22%)
Sep 11, 2026, 4:00 PM EDT - Market closed
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $448.98 million as of September 11, 2026. Its market cap has increased by 158.26% in one year.
Market Cap
448.98M
Enterprise Value
282.55M
1-Year Change
158.26%
Ranking
Category
Stock Price
$7.26
ChartMarket Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $448.98M, a decrease of -50.01%. That is a compound annual growth rate of -23.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 448.98M | -16.39% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ARS Pharmaceuticals | 473.37M |
| Prelude Therapeutics | 472.75M |
| Puma Biotechnology | 470.78M |
| Cabaletta Bio | 462.86M |
| Prothena Corporation | 458.44M |
| Ginkgo Bioworks Holdings | 454.55M |
| Rezolute | 440.85M |
| C4 Therapeutics | 431.82M |